|
REVIEW ARTICLE
Tomris Úzben
PATHOLOGY OF CEREBRAL ISCHAEMIA
Mechanisms Involved in Neuronal Damage………………………………………………………………………………………………….85
Gordana Kocić, Dušica Pavlović, Vidosava B. Đorđević,
Gordana Bjelaković, Ivana Stojanović
ROLE OF NITRIC OXIDE AND PEROXYNITRITE IN APOPTOSIS–RELATION
TO ENDONUCLEASE ACTIVITY……………………………………………………………………………………………………………………..93
Mirjana Đerić
PATHOPHYSIOLOGY AND CLINICAL SIGNIFICANCE OF ATHEROGENIC LIPOPROTEIN
PHENOTYPE AND SMALL DENSE LDL PARTICLES…………………………………………………………………………………..101
Slobodan Obradović, Slavka Mandić-Radić, Dragan Dinčić, Vesna Subota, Branko Gligić
HEMOSTAZNI POREMEĆAJI U AKUTNOM INFARKTU MIOKARDA……………………………………………………………..109
Tatjana Vodnik, Svetlana Ignjatović, Nada Majkić-Singh
PARAMETRI HEMOSTAZE KAO POKAZATELJI HIPERKOAGULABILNOSTI U TRUDNOĆI…………………………119
Duško Mirković, Nada Majkić-Singh, Svetlana Ignjatović
HOMOCISTEIN: HEMIJA, METABOLIZAM I ULOGA U PATOFIZIOLOŠKIM PROCESIMA………………………………127
Gordana Bjelaković, Tatjana Jevtović, Ivana Stojanović, Bojko Bjelaković, Mira Ilić
BIOCHEMICAL STUDY OF HEMATOLOGICAL DISEASES IN CHILHOOD…………………………………………………..141
ORIGINAL PAPER
Slavica Kundalić, Gordana Kocić, Vladan Ćosić,
Tatjana Jevtović-Stoimenov, Vidosava B. Đorđević
THE ROLE OF XANTHINE DEHYDROGENASE / XANTHINE OXIDASE
IN ATHEROGENESIS IN PATIENTS WITH HYPERLIPIDAEMIA…………………………………………………………………….151
Zoran Mijušković, Miodrag Čolić, Ivan Zgradić, Ljiljana Rackov,
Goran Radunović, Nada Pilipović, Radmila Nikolajević, Jelica Stojanović
MANNOSE BINDING LECTIN IN SERA AND SYNOVIAL FLUIDS OF PATIENTS
WITH RHEUMATOID ARTHRITIS………………………………………………………………………………………………………………….159
Predrag Jovanović, Vidosava Đorđević,
Gordana Zlatanović, Lilika Zvezdanović, Vladan ]osić
AKTIVNOST SUPEROKSID DISMUTAZE I GLUTATION PEROKSIDAZE
U OČNOJ VODICI BOLESNIKA S PRIMARNIM GLAUKOMOM OTVORENOG UGLA……………………………………165
ERRATUM
Miroslav Demajo, Stojko Vidović, Gordana Matić
EFFECT OF ACUTE STRESS ON CIRCULATORY LEVELS OF DRENOCORTICOTROPIC
HORMONE IN RATS LOCALLY HEAD-IRRADIATED WITH X-RAYS……………………………………………………………..169
OBAVEŠTENJA – TECHNICAL REPORTS…………………………………………………………………………………………………..171
|
